Why Research Sites Should Stop Measuring Recruitment Success by Leads Alone

A Research Site launches a digital recruitment campaign. Within a few weeks, the marketing report shows: 250 leads generated.

At first glance, that sounds like success. But several questions remain unanswered.

How many people could actually be contacted? How many completed preliminary pre-screening? How many appeared potentially relevant to the Study? How many were referred to the Site? How many reached screening? How many enrolled?

Without those answers, 250 leads is primarily a measure of advertising activity — not recruitment success.

This distinction matters because one of the easiest mistakes in clinical trial recruitment is optimizing the top of the funnel while losing sight of what happens downstream. Research Sites should certainly track leads. They simply should not stop there.

A Lead Measures Interest, Not Recruitment Outcome

In digital advertising, a lead usually means that someone has completed a desired action. That might include submitting a Meta lead form, completing a landing-page registration, calling a recruitment number, requesting additional information, or beginning a pre-screening process.

All of those actions are valuable. They demonstrate that the campaign created enough relevance or curiosity for someone to respond. But the person has not necessarily become a viable participant opportunity. They may live outside a practical recruitment area, fall outside an important age range, not have the condition required by the Study, be impossible to reach, decide not to continue, fail additional screening criteria, or ultimately not enroll.

None of that means the original lead was fraudulent or worthless. It means that clinical trial recruitment contains multiple conversion stages.

Research into recruitment operations has long reflected this reality. Recruitment programs have measured outcomes such as the proportion of volunteers passing prescreening, referral-to-enrollment conversion, retention, no-shows, time to first enrollment, and advertising cost per enrolled participant — not simply the number of initial inquiries.

The advertising lead is therefore the beginning of measurement, not the end.

Why Lead Volume Can Create a False Sense of Performance

Lead volume is attractive because it is easy to understand. If one campaign generates 100 responses and another generates 300, the second one appears three times more productive. But recruitment economics do not work that simply.

Consider two hypothetical campaigns.

Campaign A — 300 leads, $18 Cost Per Lead, 60 completed preliminary pre-screens, 25 potential referrals, 10 participants reached Site screening.

Campaign B — 180 leads, $26 Cost Per Lead, 90 completed preliminary pre-screens, 55 potential referrals, 30 participants reached Site screening.

Based on CPL alone, Campaign A appears considerably better. Based on progression through the recruitment funnel, Campaign B may represent far greater value to the Research Site. These numbers are illustrative, not industry benchmarks. The point is that the denominator changes depending on what the organization is trying to accomplish.

If the objective is simply collecting contact information, CPL may be sufficient. If the objective is supporting clinical trial enrollment, the Site needs to understand what happens after the contact information arrives.

The Recruitment Funnel Needs Its Own Scorecard

A stronger reporting structure connects marketing activity with progressively more meaningful outcomes. For example:

Advertising Spend → Clicks → Inquiries / Leads → Contactable Inquiries → Pre-Screen Completions → Potentially Relevant Participants → Referrals → Site Screening → Enrollment

A Research Site does not necessarily need a complicated analytics system on day one. But it should be able to identify the major stages that determine whether recruitment dollars are producing useful outcomes.

Research on clinical-trial Site performance similarly uses recruitment and enrollment rates, screening outcomes, participant retention, and other operational measures to understand performance rather than relying on a single volume metric.

The objective is visibility. If the Site knows where people are leaving the funnel, it can begin determining why.

Metric 1: Cost Per Lead

Cost Per Lead remains useful. It is normally calculated as Advertising Spend ÷ Number of Leads. If a campaign spends $3,000 and generates 150 leads, CPL = $20.

That tells the marketing team how efficiently the advertising platform is generating responses. It can help compare creative, audiences, geographic areas, advertising channels, campaign periods, and different messaging approaches.

But CPL answers only one question: how much did it cost to generate an inquiry? It does not answer how much did it cost to generate someone who may actually progress through recruitment? That distinction is where the next metrics become important.

Metric 2: Contact Rate

Before evaluating qualification, the Site needs to know whether people can actually be reached. A simple contact rate could be expressed as Successfully Contacted Leads ÷ Total Leads.

Low contact rates can indicate several different problems: slow follow-up, incorrect contact information, calls from unidentified numbers, insufficient outreach attempts, weak confirmation messaging, communication occurring at inconvenient times, or people losing interest between registration and contact.

This metric is especially useful because poor contact performance may otherwise be misclassified as poor advertising quality. If the advertising generates appropriate interest but the recruitment operation cannot reach those people, changing the ads may solve the wrong problem.

Metric 3: Pre-Screen Completion Rate

If the recruitment process includes an approved preliminary pre-screening stage, the organization should understand how many inquiries complete it — for example, Completed Pre-Screens ÷ People Beginning Pre-Screening.

A low completion rate may reveal friction. The process may be too long, confusing, difficult on mobile devices, asking questions without sufficient context, poorly translated, technically unreliable, or introduced too early in the participant journey.

This is why funnel measurement becomes valuable. Instead of concluding that “the leads are bad,” the organization may discover that interested people are simply abandoning a difficult process.

Metric 4: Potential Referral Rate

The next question is how many inquiries progress far enough to become meaningful opportunities for the Research Site. Depending on the recruitment structure, this may be measured as Potential Referrals ÷ Completed Pre-Screens, or against total inquiries.

Terminology needs to remain consistent. A marketing organization should not call someone “qualified” if only the Research Site can make the relevant eligibility determination. A safer operational distinction is between inquiry, preliminary pre-screen result, potential referral, Site screening, and enrolled participant. Clear labels make reporting more useful and reduce the risk of creating unrealistic expectations.

Metric 5: Cost Per Referral

Once referrals are being tracked, the economic picture changes considerably. Suppose:

Campaign A — $5,000 spend, 250 leads, 25 referrals. CPL = $20. Cost Per Referral = $200.

Campaign B — $5,000 spend, 150 leads, 50 referrals. CPL = $33.33. Cost Per Referral = $100.

Looking only at CPL, Campaign A wins. Looking at Cost Per Referral, the interpretation reverses completely. Again, these are illustrative figures. They demonstrate why Sites that evaluate vendors exclusively by Cost Per Lead may inadvertently reward campaigns that generate cheap responses rather than stronger recruitment opportunities.

Metric 6: Referral-to-Screening Rate

Marketing performance should eventually connect with Site performance. If 100 referrals reach a Site but only 10 proceed to formal screening, the organization needs to understand what happened.

Possible explanations include preliminary criteria that were too broad, referrals that were not contacted effectively, people declining after learning more, travel requirements becoming a barrier, Site capacity slowing follow-up, additional protocol criteria eliminating candidates, or campaign expectations that did not align sufficiently with the actual Study.

This is where marketing and Site operations need to share data. Neither side can optimize the entire funnel independently. Research on Site performance supports measuring screening and enrollment outcomes precisely because they reveal operational differences that raw recruitment volume cannot show.

Metric 7: Screening-to-Enrollment Rate

Not everyone reaching formal screening will enroll. That is expected. Clinical trials have protocol requirements that advertising cannot determine. Participants may also choose not to proceed.

The relevant question is whether the organization understands the pattern. Tracking Enrolled Participants ÷ Participants Screened can help distinguish top-of-funnel recruitment issues from later-stage Study or Site issues.

For example, a campaign could produce strong lead volume, strong pre-screen progression, strong referral volume, and strong Site screening attendance, but relatively low enrollment. At that point, repeatedly changing advertising creative may accomplish very little. The bottleneck lies deeper in the funnel. That is the advantage of measurement: it tells teams where to investigate.

Metric 8: Cost Per Enrolled Participant

Where data access and attribution allow it, one of the strongest economic measures is the cost required to produce actual enrollment. Recruitment programs have historically tracked advertising expense at protocol and campaign level and connected those expenditures to enrollment outcomes. The basic concept is Recruitment Marketing Spend ÷ Attributed Enrollments.

This metric should still be interpreted carefully. Enrollment depends on much more than advertising — protocol complexity, inclusion and exclusion criteria, competing Studies, Site performance, participant burden, geographic conditions, physician referrals, recruitment source, and Study design.

Research evaluating Site recruitment has repeatedly found that recruitment challenges are multifactorial and that there is no universal intervention that solves every enrollment problem. For this reason, Cost Per Enrollment should not become another simplistic metric. It should become part of a larger performance picture.

Not Every Recruitment Source Produces the Same Yield

Volume becomes especially misleading when multiple recruitment sources are compared. A referral from a physician, a previous Site database, Meta advertising, Google Search, community outreach, and a recruitment registry may behave very differently.

One published trial comparing provider referrals with Facebook self-referrals provides a useful example. Provider referrals produced far fewer initial referrals than Facebook, but a considerably greater proportion ultimately randomized into the trial.

That does not mean Facebook is inherently ineffective. Nor does it mean provider referrals will always be superior. The lesson is more important: recruitment sources should be evaluated by downstream yield, not simply initial volume. A high-volume channel may still be essential because it creates scale. A lower-volume channel may deliver stronger conversion. The Site needs both pieces of information to allocate resources intelligently.

Site Performance Can Make a Good Marketing Campaign Look Bad

There is another uncomfortable reality in recruitment analytics. Sometimes the advertising is working. The Site is the bottleneck.

Consider a campaign that consistently produces apparently relevant participant referrals. If Site personnel call several days later, make only one contact attempt, fail to document outcomes, do not update referral status, have insufficient screening appointments, or cannot communicate effectively in the participant’s preferred language, downstream results may appear poor.

Marketing may then be blamed for low enrollment even though much of the drop-off occurred after referral. The reverse can also happen: a highly effective Site team may compensate for mediocre marketing by aggressively working every inquiry.

This is why marketing performance and Site performance need to be measured separately but connected analytically. Published Site-performance research similarly emphasizes recruitment speed, enrollment, retention, screening and other operational indicators when evaluating how effectively research locations perform.

A Recruitment Dashboard Should Tell a Story

A useful dashboard should allow a Research Site to answer several basic questions without digging through multiple spreadsheets.

Advertising. How much did we spend? How many people did we reach? How many inquiries did we generate? What was our CPL?

Engagement. How many inquiries could we contact? How quickly? How many completed preliminary pre-screening?

Referral. How many potential referrals were generated? What was Cost Per Referral? Which sources produced the strongest referral rate?

Site. How many referrals were contacted? How many scheduled screening? How many attended? How many enrolled?

Performance. Where is the largest drop-off? Which location performs best? Which creative or channel produces stronger downstream outcomes? Is the bottleneck advertising, recruitment workflow, or Site operations?

The dashboard does not need to look impressive. It needs to support decisions.

Better Metrics Change Marketing Decisions

When a Research Site begins measuring deeper into the funnel, optimization changes.

Instead of “turn off the campaign with the expensive leads,” the discussion becomes “Campaign B has a higher CPL but produces referrals at half the cost.”

Instead of “we need more leads,” the team may discover “we already have enough inquiries; our largest loss occurs before initial contact.”

Instead of “Meta isn’t working in this city,” the data may show “the city produces excellent pre-screen results, but most referrals are outside practical travel distance.”

These are much more useful business decisions. And they are only possible when recruitment is measured beyond lead volume.

The Right Metric Depends on Who Is Asking

Different stakeholders legitimately care about different stages.

Marketing Team may focus on CPM, CTR, CPC, CPL, creative performance, and conversion rate.

Recruitment Team may focus on contact rate, pre-screen completion, preliminary qualification, referral rate, and response time.

Research Site may focus on screening appointments, screen failures, enrollments, no-shows, and recruitment pace.

CRO or Sponsor may focus on enrollment by Site, enrollment velocity, geographic performance, cost efficiency, and progress toward Study targets.

None of these perspectives is necessarily wrong. The problem occurs when one metric is used to represent the entire system.

Stop Asking Only “How Many Leads Did We Get?”

Lead generation is important. Without initial interest, there is no digital recruitment funnel. But Research Sites should resist allowing lead counts to become the primary definition of recruitment success.

The more useful questions are: How many inquiries were contactable? How many progressed through preliminary pre-screening? How many became meaningful referrals? How many reached Site screening? How many ultimately enrolled? How much did we spend at each meaningful stage? Where are we losing potential participants? Which recruitment sources create the greatest downstream value?

Once those questions become part of routine reporting, marketing stops being judged merely by how many forms it fills. It begins to be measured by how effectively it contributes to the Study’s recruitment objectives. That is a much stronger standard for clinical trial recruitment performance.

Frequently Asked Questions

What is the most important clinical trial recruitment metric?

There is no single metric that accurately represents the entire recruitment process. Leads, contact rates, pre-screen progression, referrals, screening, enrollment, recruitment speed, and cost each provide different information. The most useful measurement system connects multiple stages of the recruitment funnel.

Is Cost Per Lead still useful for clinical trial recruitment?

Yes. CPL is useful for evaluating advertising efficiency. The problem arises when it is treated as proof of recruitment success without considering the quality and downstream progression of those leads.

What is Cost Per Referral?

Cost Per Referral measures recruitment marketing expenditure relative to the number of inquiries that progress to the organization’s defined referral stage. The exact definition of a referral should be established consistently before comparing campaigns.

Why can a campaign with a higher CPL perform better?

A more expensive lead can still generate greater value if those inquiries progress through pre-screening, referral, Site screening, and enrollment at higher rates. Downstream conversion can therefore outweigh differences in initial lead cost.

Should Research Sites track enrollment by advertising source?

Where attribution and privacy requirements allow it, connecting recruitment sources to downstream outcomes can provide valuable information about which channels generate meaningful recruitment results. Attribution should be implemented consistently and interpreted alongside Site and protocol factors.